Literature DB >> 10952495

Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children.

B Jarzab1, D Handkiewicz Junak, J Włoch, B Kalemba, J Roskosz, A Kukulska, Z Puch.   

Abstract

At most centres, the standard treatment for differentiated thyroid cancer (DTC) comprises total thyroidectomy, radioiodine treatment and thyroid-stimulating hormone (TSH) suppressive therapy. There is, however, considerable disagreement over the appropriate treatment for DTC in children. Some dispute the use of total thyroidectomy and/or question the routine application of iodine-131 therapy in children. The aim of this study was to perform a retrospective analysis of treatment results and prognostic factors for DTC in children treated at our centre. The study included 109 children with DTC (aged 6-17 years). The primary treatment comprised total thyroidectomy in 81 cases, radioiodine therapy in 85 cases and TSH suppressive therapy with L-thyroxine in all patients. Uni- and multivariate analysis of prognostic factors for disease-free survival was performed using the Cox regression method. The actuarial survival rate was 100%, and the 5- and 10-year actuarial disease-free survival rates were 80% and 61% respectively. Univariate analysis revealed that older age, total thyroidectomy and radioiodine treatment had a positive impact on disease-free survival whereas there were no statistical differences with regard to the child's sex, histological type of cancer or lymph node status. On multivariate analysis, radical surgery was estimated to be the most significant factor (P=0.007) for disease-free survival, while less than total thyroidectomy increased the relative risk of relapse by a factor of 10. Radioiodine treatment decreased the relative risk of relapse by a factor of 5, but with borderline significance (P=0.07). Permanent postoperative complications were observed in 17% of children: in 11 laryngeal palsy occurred, in six there was hypoparathyroidism, and one suffered from both. It is concluded that total thyroidectomy and radioiodine treatment significantly improve recurrence-free survival in children and should be routinely applied even in young children as the primary treatment of DTC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952495     DOI: 10.1007/s002590000271

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  30 in total

1.  Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.

Authors:  Ning Qu; Ling Zhang; Zhong-Wu Lu; Qing-Hai Ji; Shu-Wen Yang; Wen-Jun Wei; Yan Zhang
Journal:  Tumour Biol       Date:  2015-12-22

Review 2.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

Review 3.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.

Authors:  Scott A Rivkees; Ernest L Mazzaferri; Frederik A Verburg; Christoph Reiners; Markus Luster; Christopher K Breuer; Catherine A Dinauer; Robert Udelsman
Journal:  Endocr Rev       Date:  2011-08-31       Impact factor: 19.871

4.  Papillary thyroid carcinoma in a 5-year-old child-case report.

Authors:  B N Gayathri; A Sagayaraj; S Prabhakara; T N Suresh; Merchant Shuaib; S M Azeem Mohiyuddin
Journal:  Indian J Surg Oncol       Date:  2014-03-11

5.  Differentiated thyroid cancer in children and adolescents.

Authors:  D Giuffrida; C Scollo; G Pellegriti; G Lavenia; M P Iurato; V Pezzin; A Belfiore
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

Review 6.  Initial treatment of pediatric differentiated thyroid cancer: a review of the current risk-adaptive approach.

Authors:  Marguerite T Parisi; Hedieh Khalatbari; Sanjay R Parikh; Adina Alazraki
Journal:  Pediatr Radiol       Date:  2019-10-16

7.  Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancer.

Authors:  Frederik A Verburg; Uwe Mäder; Markus Luster; Heribert Hänscheid; Christoph Reiners
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-13       Impact factor: 9.236

8.  Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008.

Authors:  Ian D Hay; Tomas Gonzalez-Losada; Megan S Reinalda; Jennifer A Honetschlager; Melanie L Richards; Geoffrey B Thompson
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

9.  Differentiated thyroid carcinoma: comparison of histopathologic characteristics, clinical course, and outcome between young children and adolescents.

Authors:  M Motazedian; B Shafiei; P Vatankhah; S Hoseinzadeh; M Mirzababaee; L Fathollahi; M Ansari; N Baharfar; F Tabeie; I Neshandar Asli
Journal:  Med Oncol       Date:  2013-02-20       Impact factor: 3.064

10.  Surgical management of papillary thyroid carcinoma in childhood and adolescence: an Italian multicenter study on 250 patients.

Authors:  C Spinelli; S Strambi; L Rossi; S Bakkar; M Massimino; A Ferrari; P Collini; G Cecchetto; G Bisogno; A Inserra; F Bianco; P Miccoli
Journal:  J Endocrinol Invest       Date:  2016-04-29       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.